All In Biotech

Drug Trial Radar · NCT02171988

Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)

Comparison of Effect of Propranolol, Bisoprolol, Pyridosgitmine in Postural Orthostatic Tachycardia Syndrome (POTS) and Prognosis After Medical Treatment

Last checked: Nov 19, 2026Latest source record: Apr 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

Mar 2014

Primary completion

Feb 2016

Study completion Dec 2016

Sponsor

Lead sponsor
Seoul National University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 24, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 15 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to investigate effect of medical treatment and prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)

Conditions

  • Postural Orthostatic Tachycardia Syndrome

Interventions

  • PropranololDrug

    Start propranolol 10mg bid, and then dose up to 20mg bid after one month if tolerable

  • BisoprololDrug

    Start bisoprolol 2.5mg qd P.O, and then dose up to 5mg qd. if tolerable

  • Propranolol+pyridostigmineDrug

    Start propranolol+pyridostigmine 10mg bid +30mg bid, and then dose up to 20mg bid+30mg bid. if tolerable.

  • Bisoprolol+pyridostgmineDrug

    Start bisoprolol+pyridostgmine 2.5mg qd+30mg bid, and then, dose up to 5mg qd+30mg bid. if tolerable

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The change of the subjective symptom survey result after 3-month medical treatment.Time frame: 3 month after medical treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seoul National University Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.